Based on advances in biotechnology and neuroscience, non-invasive neuromodulation devices are poised to gain clinical importance in the coming years and to be of increasing interest to patients, clinicians, health systems, payers, and industry –

Given the growing interest in non-invasive neuromodulation technologies, the Institute of Medicine’s Forum on Neuroscience and Nervous System Disorders convened a workshop in March 2015, inviting a range of stakeholders to explore the opportunities, challenges, and ethical questions surrounding the development, regulation, and reimbursement of these devices.